Introduction
Polyomavirus transforms cells in culture and induces tumours in virus-infected animals. Three proteins expressed early in the virus life-cycle, the tumour antigens (T antigens), are responsible for these activities (Tooze, 1980) . Large-T antigen is a nuclear protein known to immortalize primary cells in culture (Strauss et al., 1990) . Middle-T antigen causes phenotypic changes associated with malignant cell growth such as altered cytoskeleton organization, reduced adhesion on a solid substratum and the ability to grow in low serum and under anchorage-independent conditions (Kaplan et al., 1989; Dilworth, 1995) .
The activity of middle-T is thought to result from its association with intraceUular signal-transducing proteins such as members of the Src family of tyrosine kinases (cSrc, Fyn, c-Yes; Courtneidge, 1989; Dilworth, 1995) , the 85 kDa subunit of a phosphatidylinositol 3-kinase (PI 3-kinase; Whitman et al., 1985) , the catalytic and regulatory subunits of protein phosphatase 2A (PP2A; Pallas et al., 1990; Walter et al., 1990 ) and the SH2-containing protein SHC (Dilworth et al., 1994; Campbell et al., 1994) whose putative role is to regulate GDP/GTP * Author for correspondence. Fax +41 61 697 3976. e-mail ballmer @ fmi.ch t Present address: Royal Postgraduate Medical Hammersmith Hospital, London W12 0NN, UK.
School, exchange factors involved in the activation of the Ras signalling pathway (Rozakis Adcock et al., 1992; Pronk et al., 1994; Sasaoka et al., 1994) . More recently, middle-T immunoprecipitates have been found to contain an additional cellular component, a member of the 14-3-3 family of proteins, some of which seem to be involved in stimulating ADP ribosylation .
Middle-T is associated with cellular membranes through a stretch of 22 hydrophobic amino acids localized close to the carboxy terminus (Carmichael et al., 1982; Kutay et al., 1993; Ito et al., 1977a) . Cell fractionation studies have shown that middle-T is predominantly associated with the plasma membrane (Ito, 1979; Ito et al., 1977a, b) , while a study using immunofluorescence light microscopy and electron microscopy points to association with internal membranes, most likely the endoplasmic reticulum (ER; Templeton et al., 1984; Dilworth et al., 1986) .
A third T antigen, small-T (Ito et al., 1977b) , whose biological function is not well defined, associates with PP2A through a sequence collinear with the amino terminus of middle-T (Pallas et al., 1990) . Small-T, together with middle-T, is responsible for deregulation of PP2A (Scheidtmann et al., 1991 ; Cayla et al., 1993) .
We investigated the localization of middle-T in mouse and rat fibroblasts using a series of monoclonal antibodies characterized recently (Dilworth & Horner, 1993) . Studying various virus mutants we found that a middle-T lacking the putative membrane anchor domain (1387T middle-T; Carmichael et al., 1982) nucleus, while the wild-type (wt) protein was concentrated in an asymmetrical perinuclear patch, most likely the ER, as shown previously (Templeton et al., 1984; Dilworth et al., 1986) . We performed a detailed analysis of the localization of middle-T employing microinjection of cDNAs encoding wt or mutant T antigen into single cells. The results show that sequences present in the domain common to middle-and small-T directed these proteins to the nucleus. Since no classical nuclear targeting signal could be identified in the amino acid sequence of these proteins they might enter the nucleus via a mechanism distinct from the classical pathway, which requires a mono-or bipartite sequence of basic residues (Kalderon et al., 1984; Garcia-Bustos et al., 1991) . Our data show that domains crucial for association with PP2A are also important for nuclear localization of these proteins and it could therefore be speculated that one of the subunits of this phosphatase mediates nuclear localization ofT antigen. This would be in agreement with recently published data showing that a significant fraction of PP2A is nuclear (Turowski et al., 1995) .
Methods
Cells and viruses. NIH 3T3 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum. Cells were infected either with wt polyomavirus (NG59RA) or with mutant virus Py1387T at a multiplicity of 10 p.f.u, per cell. After 20 h, cells were fixed and processed for immunoftuorescence. Rat embryo fibroblasts ) were grown in D M E M supplemented with 8 % fetal calf serum (FCS). For microinjection studies cells were subcultured onto glass coverslips 2 days before use.
Plasmid constructs, pSVmT has been described before (Muser et al., 1989) . pSV1387TmT is derived from pGMI01 (Ballmer-Hofer et al., 1987) . DC1 and DC2 mutations were cloned into pSVmT and pSV1387TmT by exchanging a BstXI-DraIII fragment with the corresponding sequence from pAS 101DC 1 or pAS 101 DC2 (Markland & Smith, 1987) . pSVsTDC1 and pSVsTDC2 were created by transferring the BstXI-DraIII fragment of pSVmTDC1 and pSVmTDC2, respectively, to the BstXI-and DralII-restricted pSVsT vector, pSVNG59 and pSV1387T.NG59 resulted from replacing the BstXI-DraIII fragment of pSVmT or pSV1387T with the BstX-and DraIII-digested fragment from pAT53NG59 (Cheng et al., 1986) . All genes were cloned into pcDNAINeo (Invitrogen) at the HindIII and EcoRI sites, pcDNA1387T.C120W was cloned by transferring the HindIII EcoRI fragment from pRSVMTC120W (Glenn & Eckhart, 1993) into pcDNA at HindIII and EcoRI sites and by exchanging the DraIII-digested fragment from pcDNA1387T for the corresponding fragment from pcDNAmT120W, pcDNAsT.NG59 was constructed by swapping the DraIII fragment between pcDNA1387T.NG59 and pcDNAsT.DC2.
Microinjection. REF-52 cells were microinjected using an Eppendorf 5171 micromanipulator and an Eppendorf 5242 microinjection device. Microinjection buffer (48 mM-K~HPO~, 4.5 mM-KH~PO~, 14 mMNaH~PO~) containing the expression vectors at a concentration of 0.3 gg/gl was centrifuged at 100000g for 1 h. Injected cells were incubated for 18 h in DMEM supplemented with 8% FCS prior to preparation for immunofluorescence.
Immunofluorescence. Localization of polyomavirus T antigens was studied in virus-infected NIH 3T3 or microinjected REF-52 cells at 20
and 18 h, respectively, after introduction of the corresponding DNA. The cells were fixed for 30 min in 3.7 % formaldehyde, washed in PBS and permeabilized with 1% Triton X-100 for 5 rain. After washing with PBS, cells were incubated for 1 h either with the mouse monoclonal antibody PAb762, which is directed against the common aminoterminal region of large-T, middle-T and small-T, or with mouse monoclonal antibodies PAb750, PAb754 and PAb758, which specifically recognize middle-T (Dilworth & Homer, 1993) . After washing with PBS, secondary Texas Red-conjugated goat anti-mouse antibodies (Southern Biotech) were added for 45 min. Cells were washed in PBS and mounted in gelvatol. The cellular distribution of T antigens was examined on a Leica TCS4D confocal laser scanning microscope using a 40 x NA 1.00 0-5 oil immersion or a 63 x NA 1.4 oil immersion objective lens. Analysis and quantification of the data was performed on a Silicon Graphics Indy platform using the Imaris software package from Bitplane. Approximately 10 cells were analysed for each mutant. The fraction of T antigen in the nucleus was determined as the number of voxels in the nucleus divided by the number of voxels in the entire volume of a cell. The mean and SD for each data set were determined.
Transient transfection. NIH 3T3 cells (1 x 10 ~) were plated on 10 cm plates with DMEM containing 10% calf serum and transfected 20 h later by the LipofectAMINE method (Gibco). Solution A (18 pg plasmid DNA in 1 ml Opti-MEM I; Gibco) was mixed with solution B (60 gl LipofectAMINE in 1 ml Opti-MEM I) and after 15 min, 2 ml Opti-MEM I were added. Cells were incubated with the mixture for 5 h, then 4 ml Opti-MEM I with 20 % calf serum were added. After 20 h, cells were harvested for immunoprecipitation.
Immunoprecipitation and Western blot analysis. Immunoprecipitation was performed as described (Kaech et al., 1991) . For T antigen immunoprecipitation we used a polyclonal rat BNascites. Immunoprecipitates were run on 10 % SDS-polyacrylamide gels and transferred to PVDF membranes. Membranes were blocked with 3 % gelatine in TBS and incubated for 1 h at room temperature either with the T antigen-specific antibody PAb762 or with the rabbit serum Ab65 ~77/~96 (Turowski et al., 1995) , which recognizes the p65 regulatory subunit of PP2A. After washing with Tween/Tris-buffered saline (TTBS; 0.05 % Tween 20, 20mM-Tris-HC1 pH7.5, 150mM-NaCl) the blot was incubated with biotinylated protein A in TTBS for 1 h. The membrane was washed and immunocomplexes detected by alkaline phosphatase linked to streptavidine using a chemiluminescence system (Tropix).
Results
In order to study the localization of wt and mutant middle-T antigen (1387Tmiddle-T), NIH 3T3 mouse fibroblasts were infected with polyomavirus and analysed by immunofluorescence 20 h after infection. Fig. 1 (a) shows that wt middle-T was localized in a perinuclear patch, most likely the ER, while the truncated 1387Tmiddle-T lacking the putative membrane anchor sequence was predominantly nuclear (Fig. 1 c) . This was surprising since middle-T does not contain nuclear targeting sequences and was therefore expected to be cytoplasmic.
To investigate further this phenomenon, a variety of mutant middle-T antigens that could not be expressed A. Messerschmitt and others from an entire viral genome due to interference with the large-T reading frame (Tooze, 1980) were cloned into a eukaryotic expression vector. Wt and mutant T antigenencoding constructs were introduced into REF-52 rat fibroblasts by microinjection. This approach further excluded interference with other viral proteins expressed in virus-infected cells. Fig. 1 (b) shows that wt middle-T cDNA microinjected into REF-52 cells resulted in the expression of T antigen in perinuclear structures similar to those observed in virus-infected cells, while truncated middle-T (Fig. l d) was almost exclusively nuclear. Quantification of the data using the Imaris image processing software package is shown in Fig. 6 (see below). Approximately 60% of the truncated mutant proteins were nuclear while more than 80 % were found in perinuclear structures in wt protein-expressing cells. Thus we conclude that middle-T localization is not dictated by ancillary viral proteins but rather by its ability to interact with membranes through a carboxyterminal hydrophobic domain. Truncated forms of middle-T are not cytoplasmic as expected but accumulate in the nucleus. The truncated form of middle-T is defective in binding Src tyrosine kinases, PI 3-kinase and SHC yet is still capable of interaction with PP2A (Fig. 2) . We therefore concentrated our efforts on T antigen mutants unable to bind PP2A. A series of amino-terminal mutations [NG59 (Hattori et al., 1979) ; DC1 and DC2 (Markland & Smith, 1987) ; C120W (Glenn & Eckhart, 1993) ] are known to prevent association of full-length middle-T with PP2A. These mutations, mapping to a region encompassing approximately 60 amino acids, were introduced into wt or truncated middle-T. To verify that these mutants were disabled in PP2A-binding, immunoprecipitates made with T antigen-specific antibodies were analysed on Western blots using an antiserum raised against the 65 kDa subunit of PP2A (Fig. 2) . Similar data were obtained for an antibody specific for the catalytic subunit of PP2A (data not shown).
Plasmids encoding mutant middle-T were microinjected into REF-52 cells and the localization of the expressed proteins studied by immunofluorescence. Fig.  3 shows that full length middle-T (Fig. 3 a) as well as NG59 middle-T (Fig. 3 c) were localized in perinuclear structures whereas DC1 and DC2 middle-T were predominantly cytoplasmic (Fig. 3b, d ). The same mutations introduced into the truncated nuclear form of middle-T (1387Tmiddle-T) prevented nuclear accumulation of the corresponding proteins (Fig. 4 ; compare a with b-e). The DC1 and DC2 mutant proteins were confined to the cytoplasm while C120W and NG59 were partially nuclear, with the bulk of the protein accumulating in the cytoplasm. The change in cellular distribution of the various middle-T mutants was quantified (see Fig. 6 ). The results are consistent with the pictures shown in Fig. 4 . The quantification of mutant C120W was somewhat ambiguous as indicated by the large SD. This might be a consequence of the varying amounts of protein made in individual ceils dictating the specificity of the association with cellular structures.
Truncated forms of middle-T might be considered to be functional homologues of small-T, the third protein expressed by polyomavirus in the early part of the lifecycle. This protein also associates with PP2A (Pallas et al., Cayla et al., 1993) and has been shown to be predominantly nuclear using immunofluorescence microscopy (Noda et al., 1986) . The same mutations introduced into 1387T middle-T described above were investigated in the context of small-T and found to block PP2A binding (Fig. 2) . Fig. 5 shows that wt small-T expressed from microinjected vector DNA is found both in the cytoplasm and the nucleus. When the same mutations described above for middle-T were introduced into small-T, no significant alteration in the subcellular distribution was detected. The amount of protein localized in the nucleus or the cytoplasm was quantified in a series of wt or mutant small-T-expressing cells as shown in Fig. 6 . In contrast to the corresponding truncated middle-T mutants, small-T mutants unable to bind PP2A were still partially nuclear, like the wt protein. This is most likely due to the fact that small-T is able to cross the nuclear pore complex by passive diffusion and is retained in the nucleoplasm by binding to nuclear components whereas middle-T, due to its higher molecular mass, depends on active transport facilitated through association with PP2A (Dingwall & Laskey, 1991; Paine, 1993) .
To corroborate the data presented, wt and mutant T antigen cDNA were also introduced into NIH 3T3 cells by LipofectAMINE-mediated transient transfection.
Localization of the expressed proteins was similar to that in virus-infected NIH 3T3 or microinjected REF-52 cells

A. Messerschmitt and others
(data not shown). In addition, further truncated forms of middle-T consisting of only 304 amino acids had the same properties as 1387T middle-T (data not shown).
Discussion
In this study we investigated the localization of middle-T and small-T in polyomavirus-infected and transfected cells. Middle-T localization was confined to a perinuclear patch most likely representing the ER complex. This is supported by preliminary data showing that drugs disrupting Golgi stacks had no effect on the localization of middle-T. Nocodazole, a drug profoundly affecting cytoskeletal structures and vesicular transport, however, prevented perinuclear accumulation of middle-T. Furthermore, staining for ER-specific marker proteins gave the same pattern as observed for full-length middle-T.
To our surprise we found that truncated forms of middle-T lacking the hydrophobic membrane-targeting sequence located close to the carboxy terminus were specifically localized in the nucleoplasm and excluded from nucleoli. Passive diffusion of middle-T through the nuclear pore complex can be excluded since proteins with a molecular mass above approximately 40 kDa are unable to cross the nuclear envelope. Active transport of proteins across the nuclear envelope requires a mono-or bipartite targeting signal consisting of basic amino acids (Dingwall & Laskey, 1991; Paine, 1993) . We could not find such a sequence in middle-T and suggest that this protein reaches the nucleoplasm as a passenger bound to cellular proteins carrying nuclear targeting sequences. Based on our studies with T antigen mutants we propose that amino-terminal sequences that have been shown to be essential for PP2A-binding are also required for nuclear targeting of truncated middle-T. Interestingly, all middle-T mutants unable to associate with PP2A were cytoplasmic suggesting a role of this phosphatase in nuclear targeting. These findings are in good agreement with recently published data showing that the regulatory and catalytic subunits of PP2A are also found in the nucleus (Turowski et al., 1995) .
The fact that the membrane anchor at the carboxy terminus is dominant over amino-terminal signals mediating nuclear localization is exemplified by the finding that all full-length middle-T mutants were localized either in perinuclear structures, most likely membranes, or in the cytoplasm. Since middle-T seems to be integrated into membranes post-translationally (Kutay et al., 1993) , the preferentially cytoplasmic distribution of some of the full-length middle-T mutants may result from impaired targeting to intracellular membranes.
Wt polyomavirus encodes an additional T antigen lacking a membrane targeting sequence, small-T, that is capable of association with PP2A (Pallas et al., 1990) . Small-T has a molecular mass of 22 kDa and is therefore expected to enter the nucleus by passive diffusion. This might explain why small-T mutants defective in PP2A-binding due to amino-terminal mutations still enter the nucleus. Once in the nucleus both wt and mutant small-T might associate with nucleoplasmic components resulting in nuclear accumulation. We suggest that truncated middle-T and authentic small-T might be functionally equivalent: in virus mutants lacking middle-T, smalt-T might at least partially compensate for this defect, presumably by provoking the necessary modifications of PP2A activity or specificity required for efficient virus replication (Liang et al., 1984; Garcea et al., 1989) . The 1387T virus expressing truncated middle-T and normal small-T grows almost like wt (Carmichael et al., 1982; Templeton et al., 1986) , hinting at the possibility that the truncated mutant protein cooperates with small-T in the final steps of virus encapsidation as suggested before (Garcea et al., 1989) . Hr-t mutant viruses, lacking functional small-and middle-T, grow very poorly and require special permissive cells for efficient replication (Garcea & Benjamin, 1983; Benjamin, 1982) . In these cells the function of small-and middle-T antigens might be supplied in trans by cellular factors.
A likely function of small-and middle-T is their ability to promote increased coat protein phosphorylation late in the replicative cycle as shown before (Garcea & Benjamin, 1983; Garcea et al., 1985) . Nuclear PP2A has the capacity to dephosphorylate VP1, resulting in poor encapsidation efficiency of the virus. Upon binding to T antigen the specificity of PP2A might change as suggested before (Cayla et al., 1993) allowing increased steady state phosphorylation of cellular and viral phosphoproteins. Since virus encapsidation occurs in the nucleus (Delos et al., 1993; Forstova et al., 1993; Montross et al., 1991) a nuclear form of T antigen might be required to maintain high levels of VP1 phosphorylation required during the final steps of the replicative cycle. In agreement with this concept it has been shown recently that phosphorylation of VP1 at Thr-156 is required for encapsidation of the virus (Li & Garcea, 1994) .
Addressing the relevance of our findings for the lifecycle of polyomavirus we looked for nuclear middle-T in virus-infected cells. With a new set of highly specific middle-T monoclonal antibodies (Dilworth & Homer, 1993) and the high sensitivity of a confocal microscope we measured the amount of middle-T in the nucleus of infected cells. These cells showed a 10-100-fold increase in average fluorescence intensity in the nucleus as compared with uninfected control cells. This accounts for approximately 10% of the signal observed in an infected cell using a large-T-specific antibody, suggesting that a small fraction of middle-T might be present in the nucleus of virus-infected ceils. Since full length middle-T does not enter the nucleus as shown in this study we suspect that truncated forms are made during the replicative cycle of the virus. They might be derived from the intact protein by proteolytic degradation, Alternatively, cryptic splice sites upstream from the sequence coding for the hydrophobic membrane anchor might enable the virus to form a fourth T antigen by alternative splicing of the primary transcript. Finally, truncated middle-T lacking the hydrophobic carboxy terminus might arise by frameshifting as shown earlier (Wilson et al., 1986) . These possibilities are currently being investigated.
